Photodynamic therapy for recurrent myopic choroidal neovascularisation after limited macular translocation surgery.
作者信息
Chan W-M, Lam D S C, Liu D T L, Wong T-H, Yuen K S C
出版信息
Br J Ophthalmol. 2003 Sep;87(9):1188-9. doi: 10.1136/bjo.87.9.1188.
Abstract
摘要
相似文献
1
Photodynamic therapy for recurrent myopic choroidal neovascularisation after limited macular translocation surgery.
Br J Ophthalmol. 2003 Sep;87(9):1188-9. doi: 10.1136/bjo.87.9.1188.
2
Choroidal neovascularisation in pathological myopia: an update in management.
Br J Ophthalmol. 2005 Nov;89(11):1522-8. doi: 10.1136/bjo.2005.074716.
3
Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.
Am J Ophthalmol. 2007 Jan;143(1):68-76. doi: 10.1016/j.ajo.2006.09.041. Epub 2006 Oct 19.
4
High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy.
Br J Ophthalmol. 2006 Nov;90(11):1361-2. doi: 10.1136/bjo.2006.094201. Epub 2006 Jul 19.
5
Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
Eye (Lond). 2005 Aug;19(8):829-30. doi: 10.1038/sj.eye.6701680.
6
Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
Br J Ophthalmol. 2003 Feb;87(2):173-6. doi: 10.1136/bjo.87.2.173.
7
Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.
Br J Ophthalmol. 2003 Jul;87(7):856-9. doi: 10.1136/bjo.87.7.856.
8
Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.
Br J Ophthalmol. 2016 Oct;100(10):1337-40. doi: 10.1136/bjophthalmol-2015-307802. Epub 2016 Jan 20.
9
Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings.
Br J Ophthalmol. 2003 Aug;87(8):975-6. doi: 10.1136/bjo.87.8.975.
10
[Dynamic phototherapy with silicone oil in treating choroidal subfoveal neovascularization in high myopia].
J Fr Ophtalmol. 2011 Oct;34(8):561.e1-4. doi: 10.1016/j.jfo.2011.03.007. Epub 2011 May 12.
引用本文的文献
1
Choroidal neovascularisation in pathological myopia: an update in management.
Br J Ophthalmol. 2005 Nov;89(11):1522-8. doi: 10.1136/bjo.2005.074716.
本文引用的文献
1
Pathologic myopia: where are we now?
Am J Ophthalmol. 2002 Nov;134(5):645-60. doi: 10.1016/s0002-9394(02)01883-4.
2
Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report.
Am J Ophthalmol. 2002 Jul;134(1):69-74. doi: 10.1016/s0002-9394(02)01511-8.
3
Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal.
Am J Ophthalmol. 2002 Apr;133(4):530-6. doi: 10.1016/s0002-9394(02)01335-1.
4
5
Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration.
Am J Ophthalmol. 2001 Jan;131(1):90-100. doi: 10.1016/s0002-9394(00)00769-8.
6
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Arch Ophthalmol. 2000 Mar;118(3):327-36. doi: 10.1001/archopht.118.3.327.
7
Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study.
Am J Ophthalmol. 1999 Aug;128(2):135-46. doi: 10.1016/s0002-9394(99)00207-x.
Zotero 插件